Form 4 Tracker
NEUROCRINE BIOSCIENCES INC
NBIX

23 insider filings · Latest: May 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 12, 2026May 14 8:45 PMLeslie V NorwalkDirector
Sale
3,810$155.01$590.6K2,429(D)

View →

May 12, 2026May 12 6:35 PMNorwalk Leslie V
Proposed Sale
6,310$162.92$1.0M

View →

Jan 16, 2026Jan 20 11:56 PMKyle GanoDirector, Chief Executive Officer
Sale
36,400$132.70$4.8M140,407(D)

View →

Jan 16, 2026Jan 16 9:21 PMKYLE GANO
Proposed Sale
36,400$133.35$4.9M

View →

Dec 15, 2025Dec 15 3:58 PMNorwalk Leslie V
Proposed Sale
11,250$155.11$1.7M

View →

Dec 8, 2025Dec 8 9:35 PMDARIN LIPPOLDT
Proposed Sale
4,376$155.51$680.5K

View →

Dec 3, 2025Dec 3 9:36 PMGARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012
Proposed Sale
15,000$152.48$2.3M

View →

Nov 28, 2025Nov 28 6:20 PMERIC BENEVICH
Proposed Sale
5,970$151.58$904.9K

View →

Nov 25, 2025Nov 25 9:25 PMGEORGE MORROW
Proposed Sale
15,000$141.25$2.1M

View →

Nov 4, 2025Nov 6 2:09 AMGano Kyle
Proposed Sale
300$141.97$42.6K

View →

Nov 5, 2025Nov 5 9:19 PMWILLIAM H. RASTETTER
Proposed Sale
18,000$143.19$2.6M

View →

Aug 7, 2025Aug 7 8:24 PMKEVIN CHARLES GORMAN
Proposed Sale
106,322$128.43$13.7M

View →

Jul 10, 2025Jul 10 8:32 PMINGRID DELAET
Proposed Sale
457$133.51$61.0K

View →

Jul 2, 2025Jul 2 8:22 PMJUDE ONYIA
Proposed Sale
80,181$128.00$10.3M

View →

May 27, 2025May 27 8:38 PMKEVIN CHARLES GORMAN
Proposed Sale
9,613$120.18$1.2M

View →

May 5, 2025May 5 8:40 PMWILLIAM H. RASTETTER
Proposed Sale
30,000$109.68$3.3M

View →

Feb 14, 2025Feb 14 9:12 PMEIRY WYN ROBERTS
Proposed Sale
500$115.04$57.5K

View →

Feb 13, 2025Feb 13 9:38 PMSTEPHEN A SHERWIN
Proposed Sale
13,831$117.18$1.6M

View →

Feb 13, 2025Feb 13 9:38 PMMATTHEW ABERNETHY
Proposed Sale
1,352$117.18$158.4K

View →

Feb 13, 2025Feb 13 9:37 PMMATTHEW C ABERNETHY
Proposed Sale
1,206$117.18$141.3K

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 12, 2026Feb 17 10:45 PMDarin LippoldtChief Legal Officer
Option Exercise
1,7925,377(D)

View →

Feb 13, 2026Feb 17 10:45 PMIngrid DelaetChief Regulatory Officer
Option Exercise
2,7601,359(D)

View →

Feb 13, 2026Feb 17 10:45 PMIngrid DelaetChief Regulatory Officer
Grant/Award
36,713$124.125,479(D)

View →

Feb 12, 2026Feb 17 10:45 PMIngrid DelaetChief Regulatory Officer
Option Exercise
1,6004,801(D)

View →

Feb 13, 2026Feb 17 10:44 PMKevin Charles GormanDirector
Option Exercise
10,9815,377(D)

View →

Feb 13, 2026Feb 17 10:44 PMSanjay Chandru KeswaniChief Medical Officer
Grant/Award
42,112$124.126,285(D)

View →

Jan 31, 2026Feb 3 11:22 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
2,0960(D)

View →

Jan 31, 2026Feb 3 11:21 PMEric BenevichChief Commercial Officer
Option Exercise
2,2940(D)

View →

Jan 31, 2026Feb 3 11:06 PMMatt AbernethyChief Financial Officer
Option Exercise
2,4370(D)

View →

Jan 31, 2026Feb 3 11:05 PMJulie CookeChief Human Resources Officer
Option Exercise
1,7410(D)

View →

Jan 31, 2026Feb 3 11:04 PMIngrid DelaetChief Regulatory Officer
Option Exercise
8010(D)

View →

Jan 31, 2026Feb 3 11:03 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
2,9270(D)

View →

Jan 31, 2026Feb 3 11:02 PMKevin Charles GormanDirector
Option Exercise
5,1420(D)

View →

Jan 31, 2026Feb 3 11:01 PMDarin LippoldtChief Legal Officer
Option Exercise
2,3730(D)

View →

Jan 31, 2026Feb 3 11:01 PMJude OnyiaChief Scientific Officer
Option Exercise
2380(D)

View →

Jan 16, 2026Jan 20 11:56 PMKyle GanoDirector, Chief Executive Officer
Option Exercise
36,400$35.990(D)

View →

← Previous

Page 2 of 2